Trial of Duvelisib in Combination With Either Romidepsin or Bortezomib in Relapsed/Refractory T-cell Lymphomas
Clinical trial NCT02783625 · COMPLETED
Trial details
- NCT number
- NCT02783625
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-23
- Primary completion
- 2026-04-21
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.